{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T05:02:48Z","timestamp":1788498168893,"version":"build-2803163510"},"reference-count":185,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Lee Trust, New Zealand"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ageing Research Reviews"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.arr.2020.101152","type":"journal-article","created":{"date-parts":[[2020,8,23]],"date-time":"2020-08-23T10:12:05Z","timestamp":1598177525000},"page":"101152","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["Shared perturbations in the metallome and metabolome of Alzheimer\u2019s, Parkinson\u2019s, Huntington\u2019s, and dementia with Lewy bodies: A systematic review"],"prefix":"10.1016","volume":"63","author":[{"given":"Melissa","family":"Scholefield","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard D.","family":"Unwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garth J.S.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arr.2020.101152_bib0005","article-title":"Changes to intermediary metabolites in sporadic and LRRK2 parkinson\u2019s disease demonstrated by proton magnetic resonance spectroscopy","volume":"2015","author":"Aasly","year":"2015","journal-title":"Parkinsons Dis."},{"key":"10.1016\/j.arr.2020.101152_bib0010","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/BF03159937","article-title":"Alzheimer\u2019s and Parkinson\u2019s disease. Brain levels of glutathione, glutathione disulfide, and vitamin E","volume":"14","author":"Adams","year":"1991","journal-title":"Mol. Chem. Neuropathol."},{"key":"10.1016\/j.arr.2020.101152_bib0015","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s12291-008-0081-8","article-title":"Serum copper in Alzheimer\u2019s disease and vascular dementia","volume":"23","author":"Agarwal","year":"2008","journal-title":"Indian J. Clin. Biochem."},{"key":"10.1016\/j.arr.2020.101152_bib0020","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1007\/s007020050127","article-title":"Cerebrospinal fluid selenium and chromium levels in patients with Parkinson\u2019s disease","volume":"105","author":"Aguilar","year":"1998","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.arr.2020.101152_bib0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011252","article-title":"Metallomic profiling and linkage map analysis of early Parkinson\u2019s disease: a new insight to aluminum marker for the possible diagnosis","volume":"5","author":"Ahmed","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.arr.2020.101152_bib0030","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s10534-011-9504-8","article-title":"Transition metal abnormalities in progressive dementias","volume":"25","author":"Akatsu","year":"2012","journal-title":"Biometals"},{"key":"10.1016\/j.arr.2020.101152_bib0035","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jinorgbio.2015.08.005","article-title":"Redox-implications associated with the formation of complexes between copper ions and reduced or oxidized glutathione","volume":"154","author":"Aliaga","year":"2016","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.arr.2020.101152_bib0040","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jtemb.2007.05.001","article-title":"Elemental profile of cerebrospinal fluid in patients with Parkinson\u2019s disease","volume":"21","author":"Alimonti","year":"2007","journal-title":"J. Trace Elem. Med. Biol."},{"key":"10.1016\/j.arr.2020.101152_bib0045","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1080\/10284150500484638","article-title":"Niacin improved rigidity and bradykinesia in a Parkinson\u2019s disease patient but also caused unacceptable nightmares and skin rash - a case report","volume":"8","author":"Alisky","year":"2005","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.arr.2020.101152_bib0050","doi-asserted-by":"crossref","DOI":"10.1111\/bpa.12592","article-title":"Purine-related metabolites and their converting enzymes are altered in frontal, parietal and temporal cortex at early stages of Alzheimer\u2019s disease pathology","author":"Alonso-Andres","year":"2018","journal-title":"Brain Pathol."},{"key":"10.1016\/j.arr.2020.101152_bib0055","doi-asserted-by":"crossref","first-page":"6858","DOI":"10.1073\/pnas.78.11.6858","article-title":"Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis","volume":"78","author":"Ames","year":"1981","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1016\/j.arr.2020.101152_bib0060","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jalz.2017.09.011","article-title":"Evidence for brain glucose dysregulation in Alzheimer\u2019s disease","volume":"14","author":"An","year":"2018","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2020.101152_bib0065","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.brainresbull.2017.03.009","article-title":"Metabolic dysfunction in parkinson\u2019s disease: bioenergetics, redox homeostasis and central carbon metabolism","volume":"133","author":"Anandhan","year":"2017","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.arr.2020.101152_bib0070","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/mds.21502","article-title":"Low plasma uric acid level in Parkinson\u2019s disease","volume":"22","author":"Annanmaki","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.arr.2020.101152_bib0075","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.clinbiochem.2006.09.005","article-title":"Determination of malondialdehyde, reduced glutathione levels and APOE4 allele frequency in late-onset Alzheimer\u2019s disease in Denizli, Turkey","volume":"40","author":"Aybek","year":"2007","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.arr.2020.101152_bib0080","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/ana.23817","article-title":"Ceruloplasmin dysfunction and therapeutic potential for Parkinson disease","volume":"73","author":"Ayton","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.arr.2020.101152_bib0085","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3233\/JAD-2008-15110","article-title":"Peripheral oxidative damage in mild cognitive impairment and mild Alzheimer\u2019s disease","volume":"15","author":"Baldeiras","year":"2008","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2020.101152_bib0090","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1007\/s11064-007-9352-7","article-title":"Myelin breakdown and iron changes in Huntington\u2019s disease: pathogenesis and treatment implications","volume":"32","author":"Bartzokis","year":"2007","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.arr.2020.101152_bib0095","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/BF02252924","article-title":"Amino acid concentrations in cerebrospinal fluid and plasma in Alzheimer\u2019s disease and healthy control subjects","volume":"2","author":"Basun","year":"1990","journal-title":"J. Neural Transm. Park. Dis. Dement. Sect."},{"key":"10.1016\/j.arr.2020.101152_bib0100","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10534-009-9277-5","article-title":"Serum zinc is decreased in Alzheimer\u2019s disease and serum arsenic correlates positively with cognitive ability","volume":"23","author":"Baum","year":"2010","journal-title":"Biometals"},{"key":"10.1016\/j.arr.2020.101152_bib0105","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/0006-8993(88)90844-X","article-title":"Amino acid and neuropeptide neurotransmitters in Huntington\u2019s disease cerebellum","volume":"454","author":"Beal","year":"1988","journal-title":"Brain Res."},{"key":"10.1016\/j.arr.2020.101152_bib0110","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1080\/10715760701861373","article-title":"Peripheral levels of glutathione and protein oxidation as markers in the development of Alzheimer\u2019s disease from Mild Cognitive Impairment","volume":"42","author":"Bermejo","year":"2008","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.arr.2020.101152_bib0115","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1007\/s00415-009-0063-7","article-title":"Lower serum ceruloplasmin levels correlate with younger age of onset in Parkinson\u2019s disease","volume":"255","author":"Bharucha","year":"2008","journal-title":"J. Neurol."},{"key":"10.1016\/j.arr.2020.101152_bib0120","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0197-4580(92)90017-R","article-title":"Significance of decreased lumbar CSF levels of HVA and 5-HIAA in Alzheimer\u2019s disease","volume":"13","author":"Blennow","year":"1992","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.arr.2020.101152_bib0125","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jns.2006.05.007","article-title":"Metal changes in CSF and peripheral compartments of parkinsonian patients","volume":"248","author":"Bocca","year":"2006","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.arr.2020.101152_bib0130","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/brain\/awm304","article-title":"Metabolomic profiling to develop blood biomarkers for Parkinson\u2019s disease","volume":"131","author":"Bogdanov","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.arr.2020.101152_bib0135","doi-asserted-by":"crossref","first-page":"848","DOI":"10.2967\/jnumed.111.089946","article-title":"Cerebral glucose metabolic features of Parkinson disease and incident dementia: longitudinal study","volume":"52","author":"Bohnen","year":"2011","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.arr.2020.101152_bib0140","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1007\/s11064-008-9610-3","article-title":"Free copper, ferroxidase and SOD1 activities, lipid peroxidation and NO(x) content in the CSF. A different marker profile in four neurodegenerative diseases","volume":"33","author":"Boll","year":"2008","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.arr.2020.101152_bib0145","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.neurobiolaging.2007.10.018","article-title":"CSF Mg and Ca as diagnostic markers for dementia with Lewy bodies","volume":"30","author":"Bostrom","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.arr.2020.101152_bib0150","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1177\/1533317510375083","article-title":"Copper and ceruloplasmin abnormalities in Alzheimer\u2019s disease","volume":"25","author":"Brewer","year":"2010","journal-title":"Am. J. Alzheimers Dis. Other Demen."},{"key":"10.1016\/j.arr.2020.101152_bib0155","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1177\/1533317510382283","article-title":"Subclinical zinc deficiency in Alzheimer\u2019s disease and Parkinson\u2019s disease","volume":"25","author":"Brewer","year":"2010","journal-title":"Am. J. Alzheimers Dis. Other Demen."},{"key":"10.1016\/j.arr.2020.101152_bib0160","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/0022-510X(94)90246-1","article-title":"Peripheral iron metabolism in patients with Parkinson\u2019s disease","volume":"125","author":"Cabrera-Valdivia","year":"1994","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.arr.2020.101152_bib0165","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2174\/1872214810666160615102809","article-title":"Alterations in glucose metabolism in alzheimer\u2019s disease","volume":"10","author":"Calsolaro","year":"2016","journal-title":"Recent Pat. Endocr. Metab. Immune Drug Discov."},{"key":"10.1016\/j.arr.2020.101152_bib0170","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3233\/JAD-160622","article-title":"Selenium levels in serum, red blood cells, and cerebrospinal fluid of alzheimer\u2019s disease patients: a report from the australian imaging, biomarker & lifestyle flagship study of ageing (AIBL)","volume":"57","author":"Cardoso","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2020.101152_bib0175","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jns.2013.11.041","article-title":"Oxidative balance, homocysteine, and uric acid levels in older patients with Late Onset Alzheimer\u2019s Disease or Vascular Dementia","volume":"337","author":"Cervellati","year":"2014","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.arr.2020.101152_bib0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2013.03.018","article-title":"Mitochondrial diseases of the brain","volume":"63","author":"Chaturvedi","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.arr.2020.101152_bib0185","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.pneurobio.2013.06.004","article-title":"Decoding Alzheimer\u2019s disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies","volume":"108","author":"Chen","year":"2013","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.arr.2020.101152_bib0190","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jnutbio.2015.12.001","article-title":"Metabolic disturbances in plasma as biomarkers for Huntington\u2019s disease","volume":"31","author":"Cheng","year":"2016","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.arr.2020.101152_bib0195","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/BF00205853","article-title":"Hippocampal tin, aluminum and zinc in Alzheimer\u2019s disease","volume":"6","author":"Corrigan","year":"1993","journal-title":"Biometals"},{"key":"10.1016\/j.arr.2020.101152_bib0200","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jns.2017.04.035","article-title":"Brain iron concentrations in regions of interest and relation with serum iron levels in Parkinson disease","volume":"378","author":"Costa-Mallen","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.arr.2020.101152_bib0205","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1432-1033.1987.tb11155.x","article-title":"Iron transport and storage","volume":"164","author":"Crichton","year":"1987","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.arr.2020.101152_bib0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031501","article-title":"Metabolite profiling of Alzheimer\u2019s disease cerebrospinal fluid","volume":"7","author":"Czech","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.arr.2020.101152_bib0215","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.neurobiolaging.2013.09.034","article-title":"Copper pathology in vulnerable brain regions in Parkinson\u2019s disease","volume":"35","author":"Davies","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.arr.2020.101152_bib0220","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/ana.20663","article-title":"Serum uric acid levels and the risk of Parkinson disease","volume":"58","author":"de Lau","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.arr.2020.101152_bib0225","doi-asserted-by":"crossref","first-page":"E139","DOI":"10.1212\/WNL.0000000000005771","article-title":"Association between diabetes and subsequent Parkinson disease A record-linkage cohort study","volume":"91","author":"De Pablo-Fernandez","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2020.101152_bib0230","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0022-510X(96)00203-1","article-title":"Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer\u2019s disease: possible relation to oxidative stress","volume":"143","author":"Deibel","year":"1996","journal-title":"J. Neurol. Sci."},{"issue":"Pt 4","key":"10.1016\/j.arr.2020.101152_bib0235","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1093\/brain\/114.4.1953","article-title":"Alterations in the levels of iron, ferritin and other trace metals in Parkinson\u2019s disease and other neurodegenerative diseases affecting the basal ganglia","volume":"114","author":"Dexter","year":"1991","journal-title":"Brain"},{"key":"10.1016\/j.arr.2020.101152_bib0240","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1002\/hbm.22391","article-title":"MRI measures of corpus callosum iron and myelin in early Huntington\u2019s disease","volume":"35","author":"Di Paola","year":"2014","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.arr.2020.101152_bib0245","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1021\/acschemneuro.8b00194","article-title":"Increased Iron deposition on brain quantitative susceptibility mapping correlates with decreased cognitive function in alzheimer\u2019s disease","volume":"9","author":"Du","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.arr.2020.101152_bib0250","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.neuroimage.2012.03.056","article-title":"Elevated brain iron is independent from atrophy in Huntington\u2019s Disease","volume":"61","author":"Dumas","year":"2012","journal-title":"Neuroimage"},{"key":"10.1016\/j.arr.2020.101152_bib0255","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/B978-0-12-410502-7.00010-7","article-title":"Imaging of iron","volume":"110","author":"Dusek","year":"2013","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.arr.2020.101152_bib0260","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1128\/JB.00250-12","article-title":"Anaerobic metabolism of indoleacetate","volume":"194","author":"Ebenau-Jehle","year":"2012","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.arr.2020.101152_bib0265","doi-asserted-by":"crossref","first-page":"10723","DOI":"10.1073\/pnas.97.20.10723","article-title":"Crystal structures of bovine milk xanthine dehydrogenase and xanthine oxidase: structure-based mechanism of conversion","volume":"97","author":"Enroth","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1016\/j.arr.2020.101152_bib0270","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.3923\/pjbs.2012.1094.1097","article-title":"Serum iron and ferritin level in idiopathic Parkinson","volume":"15","author":"Farhoudi","year":"2012","journal-title":"Pak. J. Biol. Sci."},{"key":"10.1016\/j.arr.2020.101152_bib0275","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/jnnp-2016-313918","article-title":"Cerebral glucose metabolism and cognition in newly diagnosed Parkinson\u2019s disease: ICICLE-PD study","volume":"88","author":"Firbank","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.arr.2020.101152_bib0280","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00726-006-0409-8","article-title":"Free amino acid and dipeptide changes in the body fluids from Alzheimer\u2019s disease subjects","volume":"32","author":"Fonteh","year":"2007","journal-title":"Amino Acids"},{"key":"10.1016\/j.arr.2020.101152_bib0285","doi-asserted-by":"crossref","first-page":"76","DOI":"10.5387\/fms.59.76","article-title":"Heavy metals in blood and urine and its relation to depressive symptoms in Parkinson\u2019s disease patients","volume":"59","author":"Fukushima","year":"2013","journal-title":"Fukushima J. Med. Sci."},{"key":"10.1016\/j.arr.2020.101152_bib0290","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0189043","article-title":"Development of an iron-selective antioxidant probe with protective effects on neuronal function","volume":"12","author":"Garcia-Beltran","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.arr.2020.101152_bib0295","first-page":"20","article-title":"Niacin in the central nervous system: an update of biological aspects and clinical applications","author":"Gasperi","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2020.101152_bib0300","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1039\/C7MT00244K","article-title":"Subcellular compartmentalisation of copper, iron, manganese, and zinc in the Parkinson\u2019s disease brain","volume":"9","author":"Genoud","year":"2017","journal-title":"Metallomics"},{"key":"10.1016\/j.arr.2020.101152_bib0305","doi-asserted-by":"crossref","first-page":"L563","DOI":"10.1152\/ajplung.00413.2000","article-title":"Iron regulates xanthine oxidase activity in the lung","volume":"283","author":"Ghio","year":"2002","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.arr.2020.101152_bib0310","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s12011-014-0094-5","article-title":"Heavy metals and neurodegenerative diseases: an observational study","volume":"161","author":"Giacoppo","year":"2014","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.arr.2020.101152_bib0315","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3233\/JAD-170485","article-title":"Kynurenine pathway metabolites in alzheimer\u2019s disease","volume":"60","author":"Giil","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2020.101152_bib0320","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.nbd.2019.01.003","article-title":"Integrative analysis of blood metabolomics and PET brain neuroimaging data for Parkinson\u2019s disease","volume":"124","author":"Glaab","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.arr.2020.101152_bib0325","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s10072-016-2782-8","article-title":"Serum glutathione peroxidase, xanthine oxidase, and superoxide dismutase activities and malondialdehyde levels in patients with Parkinson\u2019s disease","volume":"38","author":"Gokce Cokal","year":"2017","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.arr.2020.101152_bib0330","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1046\/j.1365-2362.1999.00471.x","article-title":"Serum zinc, copper, insulin and lipids in Alzheimer\u2019s disease epsilon 4 apolipoprotein E allele carriers","volume":"29","author":"Gonzalez","year":"1999","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.arr.2020.101152_bib0335","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jtemb.2016.06.007","article-title":"Selenium levels and Glutathione peroxidase activity in the plasma of patients with type II diabetes mellitus","volume":"37","author":"Gonzalez de Vega","year":"2016","journal-title":"J. Trace Elem. Med. Biol."},{"key":"10.1016\/j.arr.2020.101152_bib0340","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1002\/elps.201400196","article-title":"Metabolomic profiling of serum in the progression of Alzheimer\u2019s disease by capillary electrophoresis-mass spectrometry","volume":"35","author":"Gonzalez-Dominguez","year":"2014","journal-title":"Electrophoresis"},{"key":"10.1016\/j.arr.2020.101152_bib0345","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jpba.2014.10.010","article-title":"Metabolite profiling for the identification of altered metabolic pathways in Alzheimer\u2019s disease","volume":"107","author":"Gonzalez-Dominguez","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.arr.2020.101152_bib0350","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1021\/ac303163f","article-title":"Investigation of the human brain metabolome to identify potential markers for early diagnosis and therapeutic targets of Alzheimer\u2019s disease","volume":"85","author":"Graham","year":"2013","journal-title":"Anal. Chem."},{"key":"10.1016\/j.arr.2020.101152_bib0355","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.3233\/JAD-140684","article-title":"Age-associated changes of brain copper, iron, and zinc in Alzheimer\u2019s disease and dementia with Lewy bodies","volume":"42","author":"Graham","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2020.101152_bib0360","doi-asserted-by":"crossref","first-page":"851","DOI":"10.3233\/JAD-141869","article-title":"Quantitative measurement of [Na+] and [K+] in postmortem human brain tissue indicates disturbances in subjects with Alzheimer\u2019s disease and dementia with Lewy bodies","volume":"44","author":"Graham","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2020.101152_bib0365","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/j.bbadis.2016.06.007","article-title":"Metabolic signatures of Huntington\u2019s disease (HD): (1)H NMR analysis of the polar metabolome in post-mortem human brain","volume":"1862","author":"Graham","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.arr.2020.101152_bib0370","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/5472792","article-title":"Amino Acid Catabolism in Alzheimer\u2019s Disease Brain: Friend or Foe?","volume":"2017","author":"Griffin","year":"2017","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.arr.2020.101152_bib0375","first-page":"779","article-title":"Huntington\u2019 disease--imbalance of amino acid levels in plasma of patients and mutation carriers","volume":"20","author":"Gruber","year":"2013","journal-title":"Ann. Agric. Environ. Med."},{"key":"10.1016\/j.arr.2020.101152_bib0380","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1007\/s10072-013-1289-9","article-title":"Alzheimer\u2019s disease: amino acid levels and brain metabolic status","volume":"34","author":"Gueli","year":"2013","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.arr.2020.101152_bib0385","first-page":"279","article-title":"Reduction of low molecular mass iron by reducing molecules present in plasma and the protective action of caeruloplasmin","volume":"5","author":"Gutteridge","year":"1991","journal-title":"J. Trace Elem. Electrolytes Health Dis."},{"key":"10.1016\/j.arr.2020.101152_bib0390","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1002\/mds.27173","article-title":"Profiling novel metabolic biomarkers for Parkinson\u2019s disease using in-depth metabolomic analysis","volume":"32","author":"Han","year":"2017","journal-title":"Mov. Disord."},{"key":"10.1016\/j.arr.2020.101152_bib0395","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1093\/jn\/122.suppl_3.636","article-title":"Copper as a cofactor and regulator of copper,Zinc superoxide-dismutase","volume":"122","author":"Harris","year":"1992","journal-title":"J. Nutr."},{"key":"10.1016\/j.arr.2020.101152_bib0400","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1136\/jnnp-2014-309676","article-title":"Identification of novel biomarkers for Parkinson\u2019s disease by metabolomic technologies","volume":"87","author":"Hatano","year":"2016","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.arr.2020.101152_bib0405","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jtemb.2004.09.003","article-title":"Serum trace element levels and the complexity of inter-element relations in patients with Parkinson\u2019s disease","volume":"18","author":"Hegde","year":"2004","journal-title":"J. Trace Elem. Med. Biol."},{"key":"10.1016\/j.arr.2020.101152_bib0410","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1586\/ern.10.136","article-title":"Cerebral glucose metabolism in preclinical and prodromal Alzheimer\u2019s disease","volume":"10","author":"Herholz","year":"2010","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.arr.2020.101152_bib0415","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/s41386-018-0090-0","article-title":"Multivariate meta-analyses of mitochondrial complex I and IV in major depressive disorder, bipolar disorder, schizophrenia, Alzheimer disease, and Parkinson disease","volume":"44","author":"Holper","year":"2019","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/j.arr.2020.101152_bib0420","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1146\/annurev-bioeng-071516-044450","article-title":"Advances in imaging brain metabolism","volume":"19","author":"Hyder","year":"2017","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"10.1016\/j.arr.2020.101152_bib0425","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s12149-014-0911-0","article-title":"Regional glucose metabolic reduction in dementia with Lewy bodies is independent of amyloid deposition","volume":"29","author":"Ishii","year":"2015","journal-title":"Ann. Nucl. Med."},{"key":"10.1016\/j.arr.2020.101152_bib0430","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0304-3940(92)90015-Y","article-title":"Increased plasma concentrations of aspartate, glutamate and glycine in Parkinson\u2019s disease","volume":"145","author":"Iwasaki","year":"1992","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.arr.2020.101152_bib0435","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00702-017-1821-9","article-title":"Dementia with Lewy bodies and Parkinson\u2019s disease-dementia: current concepts and controversies","volume":"125","author":"Jellinger","year":"2018","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.arr.2020.101152_bib0440","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0022-510X(96)00115-3","article-title":"Neurotransmitter amino acids in cerebrospinal fluid of patients with Parkinson\u2019s disease","volume":"141","author":"Jimenez-Jimenez","year":"1996","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.arr.2020.101152_bib0445","doi-asserted-by":"crossref","first-page":"e7551","DOI":"10.1371\/journal.pone.0007551","article-title":"Metabolomic profiling in LRRK2-related Parkinson\u2019s disease","volume":"4","author":"Johansen","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.arr.2020.101152_bib0450","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jalz.2010.06.001","article-title":"Metabolomic changes in autopsy-confirmed Alzheimer\u2019s disease","volume":"7","author":"Kaddurah-Daouk","year":"2011","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2020.101152_bib0455","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1007\/s10517-018-4039-4","article-title":"Role of copper dyshomeostasis in the pathogenesis of parkinson\u2019s disease","volume":"164","author":"Karpenko","year":"2018","journal-title":"Bull. Exp. Biol. Med."},{"key":"10.1016\/j.arr.2020.101152_bib0460","article-title":"Alzheimer\u2019s disease frontal cortex mitochondria show a loss of individual respiratory proteins but preservation of respiratory supercomplexes","volume":"2019","author":"Kenney","year":"2019","journal-title":"Int. J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2020.101152_bib0465","article-title":"Serum uric acid and nigral iron deposition in Parkinson\u2019s disease: a pilot study","volume":"9","author":"Kim","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.arr.2020.101152_bib0470","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.parkreldis.2018.05.022","article-title":"Association of metals with the risk and clinical characteristics of Parkinson\u2019s disease","volume":"55","author":"Kim","year":"2018","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.arr.2020.101152_bib0475","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/j.1471-4159.1992.tb09439.x","article-title":"Brain cytochrome oxidase in Alzheimer\u2019s disease","volume":"59","author":"Kish","year":"1992","journal-title":"J. Neurochem."},{"key":"10.1016\/j.arr.2020.101152_bib0480","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.3906\/sag-1407-67","article-title":"A comparison of hair and serum trace elements in patients with Alzheimer disease and healthy participants","volume":"45","author":"Koc","year":"2015","journal-title":"Turk. J. Med. Sci."},{"key":"10.1016\/j.arr.2020.101152_bib0485","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1089\/omi.2016.0106","article-title":"Metabolic biomarkers and neurodegeneration: a pathway enrichment analysis of alzheimer\u2019s disease, parkinson\u2019s disease, and amyotrophic lateral sclerosis","volume":"20","author":"Kori","year":"2016","journal-title":"OMICS"},{"key":"10.1016\/j.arr.2020.101152_bib0490","first-page":"121","article-title":"Association of Parkinson\u2019s disease with altered serum levels of lead and transition metals among South Indian subjects","volume":"51","author":"Kumudini","year":"2014","journal-title":"Indian J. Biochem. Biophys."},{"key":"10.1016\/j.arr.2020.101152_bib0495","first-page":"H1640","article-title":"Xanthine oxidase-induced injury to endothelium - role of intracellular Iron and hydroxyl radical","volume":"257","author":"Kvietys","year":"1989","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.arr.2020.101152_bib0500","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000330538","article-title":"Reduced serum caeruloplasmin levels in non-wilsonian movement disorders","volume":"66","author":"Ling","year":"2011","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.arr.2020.101152_bib0505","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1016\/j.neurobiolaging.2014.03.013","article-title":"Altered arginine metabolism in Alzheimer\u2019s disease brains","volume":"35","author":"Liu","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.arr.2020.101152_bib0510","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0006-8993(96)00782-2","article-title":"Increased regional brain concentrations of ceruloplasmin in neurodegenerative disorders","volume":"738","author":"Loeffler","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/j.arr.2020.101152_bib0515","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1007\/s11064-012-0729-x","article-title":"Serum iron, vitamin B12 and folic acid levels in Parkinson\u2019s disease","volume":"37","author":"Madenci","year":"2012","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.arr.2020.101152_bib0520","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/mds.23358","article-title":"Reduced but not oxidized cerebrospinal fluid glutathione levels are lowered in Lewy body diseases","volume":"26","author":"Maetzler","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.arr.2020.101152_bib0525","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.neulet.2007.02.077","article-title":"Iron, copper, and iron regulatory protein 2 in Alzheimer\u2019s disease and related dementias","volume":"418","author":"Magaki","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.arr.2020.101152_bib0530","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0022-510X(97)00119-6","article-title":"Changes in the concentration of amino acids in serum and cerebrospinal fluid of patients with Parkinson\u2019s disease","volume":"151","author":"Mally","year":"1997","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.arr.2020.101152_bib0535","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.biopsych.2015.04.005","article-title":"Brain glutathione levels--a novel biomarker for mild cognitive impairment and Alzheimer\u2019s disease","volume":"78","author":"Mandal","year":"2015","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.arr.2020.101152_bib0540","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3233\/JAD-142052","article-title":"Lymphocytic mitochondrial aconitase activity is reduced in Alzheimer\u2019s disease and mild cognitive impairment","volume":"44","author":"Mangialasche","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2020.101152_bib0545","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s11064-008-9851-1","article-title":"Plasma homovanillic acid and prolactin in Huntington\u2019s disease","volume":"34","author":"Markianos","year":"2009","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.arr.2020.101152_bib0550","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.parkreldis.2018.05.026","article-title":"Glucose dysregulation in Parkinson\u2019s disease: Too much glucose or not enough insulin?","volume":"55","author":"Marques","year":"2018","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.arr.2020.101152_bib0555","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1212\/WNL.42.1.223","article-title":"Cortical glucose metabolism in Huntington\u2019s disease","volume":"42","author":"Martin","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2020.101152_bib0560","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jns.2007.05.035","article-title":"Is brain lactate increased in Huntington\u2019s disease?","volume":"263","author":"Martin","year":"2007","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.arr.2020.101152_bib0565","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02252617","article-title":"Amino acid concentrations in cerebrospinal fluid and serum in Alzheimer\u2019s disease and vascular dementia","volume":"6","author":"Martinez","year":"1993","journal-title":"J. Neural Transm. Park. Dis. Dement. Sect."},{"key":"10.1016\/j.arr.2020.101152_bib0570","doi-asserted-by":"crossref","first-page":"C768","DOI":"10.1152\/ajpcell.00417.2012","article-title":"Cellular glutathione plays a key role in copper uptake mediated by human copper transporter 1","volume":"304","author":"Maryon","year":"2013","journal-title":"Am. J. Physiol., Cell Physiol."},{"key":"10.1016\/j.arr.2020.101152_bib0575","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s12031-016-0809-5","article-title":"Metals in alzheimer\u2019s and parkinson\u2019s disease: relevance to dementia with lewy bodies","volume":"60","author":"McAllum","year":"2016","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.arr.2020.101152_bib0580","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1159\/000346370","article-title":"Postmortem brain levels of urate and precursors in Parkinson\u2019s disease and related disorders","volume":"12","author":"McFarland","year":"2013","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.arr.2020.101152_bib0585","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1089\/ars.2019.7762","article-title":"Is Cerebrospinal Fluid Superoxide Dismutase 1 a Biomarker of Tau But Not Amyloid-Induced Neurodegeneration in Alzheimer\u2019s Disease?","volume":"31","author":"McLimans","year":"2019","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.arr.2020.101152_bib0590","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s007020050160","article-title":"Cerebrospinal fluid levels of selenium in patients with Alzheimer\u2019s disease","volume":"106","author":"Meseguer","year":"1999","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.arr.2020.101152_bib0595","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0022-510X(97)00069-5","article-title":"Decreased cerebrospinal fluid levels of neutral and basic amino acids in patients with Parkinson\u2019s disease","volume":"150","author":"Molina","year":"1997","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.arr.2020.101152_bib0600","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s007020050071","article-title":"Cerebrospinal fluid levels of transition metals in patients with Alzheimer\u2019s disease","volume":"105","author":"Molina","year":"1998","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.arr.2020.101152_bib0605","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s007020050057","article-title":"Cerebrospinal fluid levels of non-neurotransmitter amino acids in patients with Alzheimer\u2019s disease","volume":"105","author":"Molina","year":"1998","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.arr.2020.101152_bib0610","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0304-3940(02)01026-1","article-title":"Cerebrospinal fluid and plasma concentrations of nitric oxide metabolites are increased in dementia with Lewy bodies","volume":"333","author":"Molina","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.arr.2020.101152_bib0615","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s00702-004-0202-3","article-title":"Neurotransmitter amino acid in cerebrospinal fluid of patients with dementia with Lewy bodies","volume":"112","author":"Molina","year":"2005","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.arr.2020.101152_bib0620","doi-asserted-by":"crossref","first-page":"737","DOI":"10.3233\/JAD-151037","article-title":"Patterns of brain Iron accumulation in vascular dementia and alzheimer\u2019s dementia using quantitative susceptibility mapping imaging","volume":"51","author":"Moon","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2020.101152_bib0625","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s00726-017-2417-2","article-title":"Glucose transportation in the brain and its impairment in Huntington disease: one more shade of the energetic metabolism failure?","volume":"49","author":"Morea","year":"2017","journal-title":"Amino Acids"},{"key":"10.1016\/j.arr.2020.101152_bib0630","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3233\/JAD-2011-111841","article-title":"Altered serum Iron and copper homeostasis predicts cognitive decline in mild cognitive impairment","volume":"29","author":"Mueller","year":"2012","journal-title":"J. Alzheimer Dis."},{"key":"10.1016\/j.arr.2020.101152_bib0635","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jchromb.2018.05.031","article-title":"Widely targeted metabolomics of Alzheimer\u2019s disease postmortem cerebrospinal fluid based on 9-fluorenylmethyl chloroformate derivatized ultra-high performance liquid chromatography tandem mass spectrometry","volume":"1091","author":"Muguruma","year":"2018","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.arr.2020.101152_bib0640","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0146480","article-title":"A metabolic study of Huntington\u2019s disease","volume":"11","author":"Nambron","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.arr.2020.101152_bib0645","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.nicl.2018.06.020","article-title":"Regional cortical perfusion on arterial spin labeling MRI in dementia with Lewy bodies: associations with clinical severity, glucose metabolism and tau PET","volume":"19","author":"Nedelska","year":"2018","journal-title":"Neuroimage Clin."},{"key":"10.1016\/j.arr.2020.101152_bib0650","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.3233\/JAD-142925","article-title":"A blood-based, 7-metabolite signature for the early diagnosis of Alzheimer\u2019s disease","volume":"45","author":"Olazaran","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2020.101152_bib0655","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1038\/tp.2011.55","article-title":"Metabolome in progression to Alzheimer\u2019s disease","volume":"1","author":"Oresic","year":"2011","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.arr.2020.101152_bib0660","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0140-6736(87)90827-0","article-title":"Raised cerebrospinal-fluid copper concentration in Parkinson\u2019s disease","volume":"2","author":"Pall","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.arr.2020.101152_bib0665","first-page":"38","article-title":"Elevated serum copper and ceruloplasmin levels in Alzheimer\u2019s disease","volume":"6","author":"Park","year":"2014","journal-title":"Asia. Pac."},{"key":"10.1016\/j.arr.2020.101152_bib0670","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.bbadis.2016.06.002","article-title":"Metabolite mapping reveals severe widespread perturbation of multiple metabolic processes in Huntington\u2019s disease human brain","volume":"1862","author":"Patassini","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.arr.2020.101152_bib0675","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.clinbiochem.2015.06.014","article-title":"Association of status redox with demographic, clinical and imaging parameters in patients with Huntington\u2019s disease","volume":"48","author":"Pena-Sanchez","year":"2015","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.arr.2020.101152_bib0680","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/S0006-2952(03)00504-5","article-title":"The changing faces of glutathione, a cellular protagonist","volume":"66","author":"Pompella","year":"2003","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.arr.2020.101152_bib0685","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.genhosppsych.2008.04.011","article-title":"Rapid resolution of delusional parasitosis in pellagra with niacin augmentation therapy","volume":"30","author":"Prakash","year":"2008","journal-title":"Gen. Hosp. Psychiat."},{"key":"10.1016\/j.arr.2020.101152_bib0690","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.exger.2012.05.019","article-title":"Plasma oxidative stress parameters in men and women with early stage Alzheimer type dementia","volume":"47","author":"Puertas","year":"2012","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.arr.2020.101152_bib0695","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/mds.26218","article-title":"High nigral iron deposition in LRRK2 and Parkin mutation carriers using R2* relaxometry","volume":"30","author":"Pyatigorskaya","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.arr.2020.101152_bib0700","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3389\/fneur.2017.00328","article-title":"Study on analysis of peripheral biomarkers for Alzheimer\u2019s disease diagnosis","volume":"8","author":"Rani","year":"2017","journal-title":"Front. Neurol."},{"key":"10.1016\/j.arr.2020.101152_bib0705","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3233\/JAD-130209","article-title":"Increased iron levels and decreased tissue integrity in hippocampus of Alzheimer\u2019s disease detected in vivo with magnetic resonance imaging","volume":"37","author":"Raven","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2020.101152_bib0710","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1212\/01.wnl.0000223644.08653.b5","article-title":"Elevated cortical zinc in Alzheimer disease","volume":"67","author":"Religa","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2020.101152_bib0715","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3233\/JAD-121474","article-title":"Longitudinal analysis of serum copper and ceruloplasmin in Alzheimer\u2019s disease","volume":"34","author":"Rembach","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2020.101152_bib0720","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0197-4580(03)00031-9","article-title":"Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer\u2019s disease","volume":"24","author":"Rinaldi","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.arr.2020.101152_bib0725","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1001\/archneurol.2011.2945","article-title":"Alterations in brain transition metals in Huntington disease: an evolving and intricate story","volume":"69","author":"Rosas","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.arr.2020.101152_bib0730","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/acn3.214","article-title":"A systems-level \"misunderstanding\": the plasma metabolome in Huntington\u2019s disease","volume":"2","author":"Rosas","year":"2015","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.arr.2020.101152_bib0735","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/00002826-199502000-00007","article-title":"Cerebrospinal-fluid homovanillic-acid is reduced in untreated huntingtons-disease","volume":"18","author":"Ruiz","year":"1995","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.arr.2020.101152_bib0740","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.598","article-title":"Serum uric acid levels in Parkinson\u2019s disease and related disorders","volume":"7","author":"Sakuta","year":"2017","journal-title":"Brain Behav."},{"key":"10.1016\/j.arr.2020.101152_bib0745","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1002\/hbm.22019","article-title":"Seeking Huntington disease biomarkers by multimodal, cross-sectional basal ganglia imaging","volume":"34","author":"Sanchez-Castaneda","year":"2013","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.arr.2020.101152_bib0750","doi-asserted-by":"crossref","first-page":"35097","DOI":"10.1038\/srep35097","article-title":"Metallomic Biomarkers in Cerebrospinal fluid and Serum in patients with Parkinson\u2019s disease in Indian population","volume":"6","author":"Sanyal","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2020.101152_bib0755","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1002\/mds.22139","article-title":"Uric acid in Parkinson\u2019s disease","volume":"23","author":"Schlesinger","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.arr.2020.101152_bib0760","first-page":"22","article-title":"Determination of coenzyme a and acetyl-coenzyme a in biological samples using HPLC with UV detection","author":"Shurubor","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.arr.2020.101152_bib0765","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3109\/10715769009087980","article-title":"Quantitative effects of iron chelators on hydroxyl radical production by the superoxide-driven fenton reaction","volume":"8","author":"Smith","year":"1990","journal-title":"Free Radic. Res. Commun."},{"key":"10.1016\/j.arr.2020.101152_bib0770","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1159\/000017067","article-title":"Copper, ceruloplasmin and superoxide dismutase in patients with Alzheimer\u2019s disease. A case-control study","volume":"9","author":"Snaedal","year":"1998","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.arr.2020.101152_bib0775","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1212\/WNL.59.8.1153","article-title":"Elevation of serum copper levels in Alzheimer\u2019s disease","volume":"59","author":"Squitti","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2020.101152_bib0780","series-title":"Chemistry of Metalloproteins : Problems and Solutions in Bioinorganic Chemistry, Wiley Series in Protein and Peptide Science","first-page":"1","author":"Stephanos","year":"2014"},{"key":"10.1016\/j.arr.2020.101152_bib0785","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.bbrc.2014.04.019","article-title":"Taurine attenuates amyloid beta 1-42-induced mitochondrial dysfunction by activating of SIRT1 in SK-N-SH cells","volume":"447","author":"Sun","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.arr.2020.101152_bib0790","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.3233\/JAD-160841","article-title":"Glucose transporters in brain: in health and in alzheimer\u2019s disease","volume":"55","author":"Szablewski","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2020.101152_bib0795","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/toxsci\/kfv325","article-title":"Comparison of metal levels between postmortem brain and ventricular fluid in alzheimer\u2019s disease and nondemented elderly controls","volume":"150","author":"Szabo","year":"2016","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.arr.2020.101152_bib0800","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1159\/000330467","article-title":"Ceruloplasmin and iron proteins in the serum of patients with Alzheimer\u2019s disease","volume":"1","author":"Torsdottir","year":"2011","journal-title":"Dement. Geriatr. Cogn. Dis. Extra"},{"key":"10.1016\/j.arr.2020.101152_bib0805","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1002\/mds.27132","article-title":"Distinct metabolomic signature in cerebrospinal fluid in early parkinson\u2019s disease","volume":"32","author":"Trezzi","year":"2017","journal-title":"Mov. Disord."},{"key":"10.1016\/j.arr.2020.101152_bib0810","first-page":"8","article-title":"Identification of altered metabolic pathways in plasma and CSF in mild cognitive impairment and alzheimer\u2019s disease using metabolomics","author":"Trushina","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.arr.2020.101152_bib0815","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.3233\/JAD-161143","article-title":"Cortical Iron Reflects severity of alzheimer\u2019s disease","volume":"60","author":"van Duijn","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2020.101152_bib0820","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s12011-017-1042-y","article-title":"The relationship between copper, Iron, and selenium levels and alzheimer disease","volume":"181","author":"Vaz","year":"2018","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.arr.2020.101152_bib0825","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s12011-015-0503-4","article-title":"Prolidase-associated trace elements (Mn, Zn, Co, and Ni) in the patients with parkinson\u2019s disease","volume":"171","author":"Verma","year":"2016","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.arr.2020.101152_bib0830","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jtemb.2010.02.002","article-title":"Alterations of plasma magnesium, copper, zinc, iron and selenium concentrations and some related erythrocyte antioxidant enzyme activities in patients with Alzheimer\u2019s disease","volume":"24","author":"Vural","year":"2010","journal-title":"J. Trace Elem. Med. Biol."},{"key":"10.1016\/j.arr.2020.101152_bib0835","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jns.2014.10.024","article-title":"A novel treatment target for Parkinson\u2019s disease","volume":"347","author":"Wakade","year":"2014","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.arr.2020.101152_bib0840","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3233\/JAD-143108","article-title":"Serum Iron, zinc, and copper levels in patients with alzheimer\u2019s disease: a replication study and meta-analyses","volume":"47","author":"Wang","year":"2015","journal-title":"J. Alzheimer Dis."},{"key":"10.1016\/j.arr.2020.101152_bib0845","article-title":"Serum uric acid levels in patients with Parkinson\u2019s disease: a meta-analysis","volume":"12","author":"Wen","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.arr.2020.101152_bib0850","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4137\/IJTR.S13958","article-title":"Kynurenic Acid levels in cerebrospinal fluid from patients with Alzheimer\u2019s disease or dementia with lewy bodies","volume":"7","author":"Wennstrom","year":"2014","journal-title":"Int. J. Tryptophan Res."},{"key":"10.1016\/j.arr.2020.101152_bib0855","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.neuropharm.2017.11.027","article-title":"Impaired peripheral glucose homeostasis and Alzheimer\u2019s disease","volume":"136","author":"Wijesekara","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.arr.2020.101152_bib0860","first-page":"12","article-title":"NMR analysis of the CSF and plasma metabolome of rigorously matched amyotrophic lateral sclerosis, Parkinson\u2019s disease and control subjects","author":"Wu","year":"2016","journal-title":"Metabolomics"},{"key":"10.1016\/j.arr.2020.101152_bib0865","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1039\/C5MB00711A","article-title":"Multi-platform mass spectrometry analysis of the CSF and plasma metabolomes of rigorously matched amyotrophic lateral sclerosis, Parkinson\u2019s disease and control subjects","volume":"12","author":"Wuolikainen","year":"2016","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.arr.2020.101152_bib0870","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.3390\/biom5021122","article-title":"Interaction between Neuromelanin and Alpha-Synuclein in parkinson\u2019s disease","volume":"5","author":"Xu","year":"2015","journal-title":"Biomolecules"},{"key":"10.1016\/j.arr.2020.101152_bib0875","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.bbadis.2016.03.001","article-title":"Graded perturbations of metabolism in multiple regions of human brain in Alzheimer\u2019s disease: snapshot of a pervasive metabolic disorder","volume":"1862","author":"Xu","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.arr.2020.101152_bib0880","doi-asserted-by":"crossref","first-page":"27524","DOI":"10.1038\/srep27524","article-title":"Elevation of brain glucose and polyol-pathway intermediates with accompanying brain-copper deficiency in patients with Alzheimer\u2019s disease: metabolic basis for dementia","volume":"6","author":"Xu","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2020.101152_bib0885","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1039\/C7MT00074J","article-title":"Evidence for widespread, severe brain copper deficiency in Alzheimer\u2019s dementia","volume":"9","author":"Xu","year":"2017","journal-title":"Metallomics"},{"key":"10.1016\/j.arr.2020.101152_bib0890","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s10534-018-0089-3","article-title":"Plasma metals as potential biomarkers in dementia: a case-control study in patients with sporadic Alzheimer\u2019s disease","volume":"31","author":"Xu","year":"2018","journal-title":"Biometals"},{"key":"10.1016\/j.arr.2020.101152_bib0895","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.parkreldis.2017.08.013","article-title":"Different iron deposition patterns in early- and middle-late-onset Parkinson\u2019s disease","volume":"44","author":"Xuan","year":"2017","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.arr.2020.101152_bib0900","first-page":"402","article-title":"Serum copper, zinc and selenium levels in Tunisian patients with Parkinson\u2019s disease","volume":"91","author":"Younes-Mhenni","year":"2013","journal-title":"Tunis. Med."},{"key":"10.1016\/j.arr.2020.101152_bib0905","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/cns.12165","article-title":"Change in plasma levels of amino acid neurotransmitters and its correlation with clinical heterogeneity in early Parkinson\u2019s disease patients","volume":"19","author":"Yuan","year":"2013","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.arr.2020.101152_bib0910","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0083060","article-title":"Assessing plasma levels of selenium, copper, iron and zinc in patients of Parkinson\u2019s disease","volume":"8","author":"Zhao","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.arr.2020.101152_bib0915","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1002\/jnr.24064","article-title":"The vicious circle of hypometabolism in neurodegenerative diseases: ways and mechanisms of metabolic correction","volume":"95","author":"Zilberter","year":"2017","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.arr.2020.101152_bib0920","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.3892\/ol.2012.931","article-title":"Redox status expressed as GSH:GSSG ratio as a marker for oxidative stress in paediatric tumour patients","volume":"4","author":"Zitka","year":"2012","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.arr.2020.101152_bib0925","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.pneurobio.2015.09.012","article-title":"Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson\u2019s disease","volume":"155","author":"Zucca","year":"2017","journal-title":"Prog. Neurobiol."}],"container-title":["Ageing Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163720302877?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163720302877?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T18:47:04Z","timestamp":1761590824000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568163720302877"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":185,"alternative-id":["S1568163720302877"],"URL":"https:\/\/doi.org\/10.1016\/j.arr.2020.101152","relation":{},"ISSN":["1568-1637"],"issn-type":[{"value":"1568-1637","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Shared perturbations in the metallome and metabolome of Alzheimer\u2019s, Parkinson\u2019s, Huntington\u2019s, and dementia with Lewy bodies: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Ageing Research Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arr.2020.101152","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2020 Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101152"}}